0
     

Report Added
Report already added
Consumer Health in Denmark

Consumer Health in Denmark

Despite sound underlying economic fundamentals, the war in Ukraine is having a negative impact, with the resultant energy crisis leading to high inflation and dampening volume sales somewhat. As a result, while overall consumer health is expected to see an increase in current value sales in 2022, constant value sales are expected to fall. In addition, while the pandemic led to a boon in consumer health, now that fears around the virus have abated, this is leading to less demand for products such...

Euromonitor International's Consumer Health in Denmark report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2017-2021, allowing you to identify the sectors driving growth. Forecasts to 2026 illustrate how the market is set to change.

Product coverage: Allergy Care, Herbal/Traditional Products, OTC, Paediatric Consumer Health, Sports Nutrition, Vitamins and Dietary Supplements, Weight Management and Wellbeing.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Consumer Health market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.
Consumer Health in Denmark

List Of Contents And Tables

CONSUMER HEALTH IN DENMARK
EXECUTIVE SUMMARY
Consumer health in 2022: The big picture
2022 key trends
Competitive landscape
Retailing developments
What next for consumer health?
MARKET INDICATORS
Table 1 Consumer Expenditure on Health Goods and Medical Services: Value 2017-2022
Table 2 Life Expectancy at Birth 2017-2022
MARKET DATA
Table 3 Sales of Consumer Health by Category: Value 2017-2022
Table 4 Sales of Consumer Health by Category: % Value Growth 2017-2022
Table 5 NBO Company Shares of Consumer Health: % Value 2018-2022
Table 6 LBN Brand Shares of Consumer Health: % Value 2019-2022
Table 7 Penetration of Private Label in Consumer Health by Category: % Value 2017-2022
Table 8 Distribution of Consumer Health by Format: % Value 2017-2022
Table 9 Distribution of Consumer Health by Format and Category: % Value 2022
Table 10 Forecast Sales of Consumer Health by Category: Value 2022-2027
Table 11 Forecast Sales of Consumer Health by Category: % Value Growth 2022-2027
APPENDIX
OTC registration and classification
Vitamins and dietary supplements registration and classification
Self-medication/self-care and preventive medicine
DISCLAIMER
DEFINITIONS
SOURCES
Summary 1 Research Sources
ANALGESICS IN DENMARK
KEY DATA FINDINGS
2022 DEVELOPMENTS
Fall in constant value sales in 2022
The analgesics landscape is highly consolidated as GlaxoSmithKline retains its lead in 2022 
CBD as an ingredient continues to grow in popularity
PROSPECTS AND OPPORTUNITIES
Moderate constant value growth over forecast period
Topical analgesics performs well
Analgesics suffers from lack of innovation
CATEGORY DATA
Table 12 Sales of Analgesics by Category: Value 2017-2022
Table 13 Sales of Analgesics by Category: % Value Growth 2017-2022
Table 14 NBO Company Shares of Analgesics: % Value 2018-2022
Table 15 LBN Brand Shares of Analgesics: % Value 2019-2022
Table 16 Forecast Sales of Analgesics by Category: Value 2022-2027
Table 17 Forecast Sales of Analgesics by Category: % Value Growth 2022-2027
COUGH, COLD AND ALLERGY (HAY FEVER) REMEDIES IN DENMARK
KEY DATA FINDINGS
2022 DEVELOPMENTS
Slight fall in constant value sales in 2022
GSK Consumer Healthcare maintains its leading position, as generics also continue to gain ground 
CBD as an ingredient continues to grow in popularity
PROSPECTS AND OPPORTUNITIES
Muted constant value growth over forecast period
Vaccines for allergies could dampen value growth of allergy remedies over long term
Climate changes leads to increased allergies
CATEGORY DATA
Table 18 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2017-2022
Table 19 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2017-2022
Table 20 NBO Company Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2018-2022
Table 21 LBN Brand Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2019-2022
Table 22 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2022-2027
Table 23 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2022-2027
DIGESTIVE REMEDIES IN DENMARK
KEY DATA FINDINGS
2022 DEVELOPMENTS
Decline in constant value sales in 2022
No significant innovation
PROSPECTS AND OPPORTUNITIES
Healthier lifestyles dampen volume sales
The ageing population will drive growth for digestive remedies
Pharmacies hold onto value share
CATEGORY DATA
Table 24 Sales of Digestive Remedies by Category: Value 2017-2022
Table 25 Sales of Digestive Remedies by Category: % Value Growth 2017-2022
Table 26 NBO Company Shares of Digestive Remedies: % Value 2018-2022
Table 27 LBN Brand Shares of Digestive Remedies: % Value 2019-2022
Table 28 Forecast Sales of Digestive Remedies by Category: Value 2022-2027
Table 29 Forecast Sales of Digestive Remedies by Category: % Value Growth 2022-2027
DERMATOLOGICALS IN DENMARK
KEY DATA FINDINGS
2022 DEVELOPMENTS
Decline in constant value sales in 2022
Omega ACO continues to lead the landscape 
Hair loss treatments benefits from society returning to normal
PROSPECTS AND OPPORTUNITIES
Moderate value and volume growth over forecast period
Ageing population and climate change support growth across the forecast period
Social stigma of certain products benefits online sales
CATEGORY DATA
Table 30 Sales of Dermatologicals by Category: Value 2017-2022
Table 31 Sales of Dermatologicals by Category: % Value Growth 2017-2022
Table 32 NBO Company Shares of Dermatologicals: % Value 2018-2022
Table 33 LBN Brand Shares of Dermatologicals: % Value 2019-2022
Table 34 LBN Brand Shares of Hair Loss Treatments: % Value 2019-2022
Table 35 Forecast Sales of Dermatologicals by Category: Value 2022-2027
Table 36 Forecast Sales of Dermatologicals by Category: % Value Growth 2022-2027
SLEEP AIDS IN DENMARK
KEY DATA FINDINGS
2022 DEVELOPMENTS
Slight increase in volume sales in 2022
No changes in the landscape in 2021, as Orkla Care continues to lead
Quality sleep seen as important part of health and wellness
PROSPECTS AND OPPORTUNITIES
Moderate constant value growth over forecast period
Players continue to innovate
Other relaxation methods could dampen demand for sleep aids
CATEGORY DATA
Table 37 Sales of Sleep Aids: Value 2017-2022
Table 38 Sales of Sleep Aids: % Value Growth 2017-2022
Table 39 NBO Company Shares of Sleep Aids: % Value 2018-2022
Table 40 LBN Brand Shares of Sleep Aids: % Value 2019-2022
Table 41 Forecast Sales of Sleep Aids: Value 2022-2027
Table 42 Forecast Sales of Sleep Aids: % Value Growth 2022-2027
EYE CARE IN DENMARK
KEY DATA FINDINGS
2022 DEVELOPMENTS
Fall in volume sales in 2022
The competitive landscape continues to be driven by well-known brands
Fierce competition eats away at margins
PROSPECTS AND OPPORTUNITIES
Increased time spent on screens supports value sales of standard eye care
Standard eye care boosted by ageing population
Allergy eye care registers higher growth
CATEGORY DATA
Table 43 Sales of Eye Care by Category: Value 2017-2022
Table 44 Sales of Eye Care by Category: % Value Growth 2017-2022
Table 45 NBO Company Shares of Eye Care: % Value 2018-2022
Table 46 LBN Brand Shares of Eye Care: % Value 2019-2022
Table 47 Forecast Sales of Eye Care by Category: Value 2022-2027
Table 48 Forecast Sales of Eye Care by Category: % Value Growth 2022-2027
WOUND CARE IN DENMARK
KEY DATA FINDINGS
2022 DEVELOPMENTS
Slight fall in volume sales in 2022
Pricing main driver of value sales
PROSPECTS AND OPPORTUNITIES
Moderate growth over forecast period
Added-value needed to stand out from the crowd
CATEGORY DATA
Table 49 Sales of Wound Care by Category: Value 2017-2022
Table 50 Sales of Wound Care by Category: % Value Growth 2017-2022
Table 51 NBO Company Shares of Wound Care: % Value 2018-2022
Table 52 LBN Brand Shares of Wound Care: % Value 2019-2022
Table 53 Forecast Sales of Wound Care by Category: Value 2022-2027
Table 54 Forecast Sales of Wound Care by Category: % Value Growth 2022-2027
VITAMINS IN DENMARK
KEY DATA FINDINGS
2022 DEVELOPMENTS
Weak performance in 2022
Orkla Care continues to lead in 2022
E-commerce now a significant channel
PROSPECTS AND OPPORTUNITIES
Healthy growth over forecast period
Innovation needed in multivitamins
Vitamins combine rather than compete with lifestyle and dietary supplements
CATEGORY DATA
Table 55 Sales of Vitamins by Category: Value 2017-2022
Table 56 Sales of Vitamins by Category: % Value Growth 2017-2022
Table 57 Sales of Multivitamins by Positioning: % Value 2017-2022
Table 58 NBO Company Shares of Vitamins: % Value 2018-2022
Table 59 LBN Brand Shares of Vitamins: % Value 2019-2022
Table 60 Forecast Sales of Vitamins by Category: Value 2022-2027
Table 61 Forecast Sales of Vitamins by Category: % Value Growth 2022-2027
DIETARY SUPPLEMENTS IN DENMARK
KEY DATA FINDINGS
2022 DEVELOPMENTS
Constant value decline in 2022, as consumers less concerned about COVID-19
Status quo remains in 2022
E-commerce now a significant channel
PROSPECTS AND OPPORTUNITIES
Segmentation key to growth over forecast period
Dietary supplements combine rather than compete with vitamins
Increased veganism sees increased demand for dietary supplements
CATEGORY DATA
Table 62 Sales of Dietary Supplements by Category: Value 2017-2022
Table 63 Sales of Dietary Supplements by Category: % Value Growth 2017-2022
Table 64 Sales of Dietary Supplements by Positioning: % Value 2017-2022
Table 65 NBO Company Shares of Dietary Supplements: % Value 2018-2022
Table 66 LBN Brand Shares of Dietary Supplements: % Value 2019-2022
Table 67 Forecast Sales of Dietary Supplements by Category: Value 2022-2027
Table 68 Forecast Sales of Dietary Supplements by Category: % Value Growth 2022-2027
WEIGHT MANAGEMENT AND WELLBEING IN DENMARK
KEY DATA FINDINGS
2022 DEVELOPMENTS
Fall in volume sales in 2022
No change in status quo in 2022
E-commerce and direct selling significant channels
PROSPECTS AND OPPORTUNITIES
Muted constant value growth over forecast period
Increasing competition from product such as protein bars
E-commerce continues to grow at healthy pace
CATEGORY DATA
Table 69 Sales of Weight Management and Wellbeing by Category: Value 2017-2022
Table 70 Sales of Weight Management and Wellbeing by Category: % Value Growth 2017-2022
Table 71 NBO Company Shares of Weight Management and Wellbeing: % Value 2018-2022
Table 72 LBN Brand Shares of Weight Management and Wellbeing: % Value 2019-2022
Table 73 Forecast Sales of Weight Management and Wellbeing by Category: Value 2022-2027
Table 74 Forecast Sales of Weight Management and Wellbeing by Category: % Value Growth 2022-2027
SPORTS NUTRITION IN DENMARK
KEY DATA FINDINGS
2022 DEVELOPMENTS
Healthy value growth in 2022
BodyLab and Nutramino continue to lead but competition is heating up
Added protein key trend
PROSPECTS AND OPPORTUNITIES
Rosey outlook over forecast period
E-commerce is key battleground
Increased number of vegan influences product development
CATEGORY DATA
Table 75 Sales of Sports Nutrition by Category: Value 2017-2022
Table 76 Sales of Sports Nutrition by Category: % Value Growth 2017-2022
Table 77 NBO Company Shares of Sports Nutrition: % Value 2018-2022
Table 78 LBN Brand Shares of Sports Nutrition: % Value 2019-2022
Table 79 Forecast Sales of Sports Nutrition by Category: Value 2022-2027
Table 80 Forecast Sales of Sports Nutrition by Category: % Value Growth 2022-2027
HERBAL/TRADITIONAL PRODUCTS IN DENMARK
KEY DATA FINDINGS
2022 DEVELOPMENTS
Fall in constant value sales in 2022
Cloetta Danmark leads sales within the fragmented competitive landscape
Dietary supplements best performing product
PROSPECTS AND OPPORTUNITIES
Moderate growth over forecast period
Focus on climate change widens consumer base
Increased segmentation way of standing out from the crowd
CATEGORY DATA
Table 81 Sales of Herbal/Traditional Products by Category: Value 2017-2022
Table 82 Sales of Herbal/Traditional Products by Category: % Value Growth 2017-2022
Table 83 NBO Company Shares of Herbal/Traditional Products: % Value 2018-2022
Table 84 LBN Brand Shares of Herbal/Traditional Products: % Value 2019-2022
Table 85 Forecast Sales of Herbal/Traditional Products by Category: Value 2022-2027
Table 86 Forecast Sales of Herbal/Traditional Products by Category: % Value Growth 2022-2027
PAEDIATRIC CONSUMER HEALTH IN DENMARK
KEY DATA FINDINGS
2022 DEVELOPMENTS
Decline in constant value sales in 2022
Major international players continue to lead
Vitamins and dietary supplements sees continued value sales
PROSPECTS AND OPPORTUNITIES
Muted growth over forecast period
Shift towards natural products over forecast period
Players focus on child-friendly design
CATEGORY DATA
Table 87 Sales of Paediatric Consumer Health by Category: Value 2017-2022
Table 88 Sales of Paediatric Consumer Health by Category: % Value Growth 2017-2022
Table 89 Sales of Paediatric Vitamins and Dietary Supplements by Type: % Value 2017-2022
Table 90 NBO Company Shares of Paediatric Consumer Health: % Value 2018-2022
Table 91 LBN Brand Shares of Paediatric Consumer Health: % Value 2019-2022
Table 92 Forecast Sales of Paediatric Consumer Health by Category: Value 2022-2027
Table 93 Forecast Sales of Paediatric Consumer Health by Category: % Value Growth 2022-2027
NRT SMOKING CESSATION AIDS IN DENMARK
KEY DATA FINDINGS
2022 DEVELOPMENTS
Volume sales unchanged in 2022
Stable competitive landscape
E-commerce now a significant channel
PROSPECTS AND OPPORTUNITIES
Bad reputation of vaping products benefits NRT products
Potential consumer base continues to contract
Little innovation expected
CATEGORY INDICATORS
Table 94 Number of Smokers by Gender 2017-2022
CATEGORY DATA
Table 95 Sales of NRT Smoking Cessation Aids by Category: Value 2017-2022
Table 96 Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2017-2022
Table 97 NBO Company Shares of NRT Smoking Cessation Aids: % Value 2018-2022
Table 98 LBN Brand Shares of NRT Smoking Cessation Aids: % Value 2019-2022
Table 99 Forecast Sales of NRT Smoking Cessation Aids by Category: Value 2022-2027
Table 100 Forecast Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2022-2027

Report Title: Consumer Health in Denmark


Your Details
Valid Invalid number

SELECT A FORMAT

ADD TO CART BUY NOW

Related Report

2023 What's Next for Vietnam Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2023 What's Next for Vietnam Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2023 What's Next for Venezuela Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2023 What's Next for Venezuela Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2023 What's Next for US Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2023 What's Next for US Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2023 What's Next for Uruguay Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2023 What's Next for Uruguay Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2023 What's Next for United Arab Emirates Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2023 What's Next for United Arab Emirates Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2023 What's Next for Ukraine Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2023 What's Next for Ukraine Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM